In order to understand whether HAS3 could serve as a potential prognostic target in human MPM, we took advantage of the bioinformatical survival analysis database PROGgeneV2, drawing from The Cancer Genome Atlas Mesothelioma (TCGA-MESO) dataset for the generation of a survival plot. Here, HAS3 is linked to cancer.